TR 30mg

A synthetic dual-receptor peptide analog characterized in vitro at GLP-1 and GIP receptor targets. Supplied as a lyophilized powder for use as a laboratory reference material in receptor-binding and analytical assays. Supplied strictly as a laboratory reagent for in-vitro research and analytical use only. Not a drug, food, cosmetic, or dietary supplement. Not for human or veterinary use.

TR also common name Tirzepatide is a synthetic peptide compound that has been studied for its activity at both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Its dual-receptor activity.

Research Use

A dual receptor agonist being studied for weight loss, type 2 diabetes, and other weight-related conditions.

Product Details:

It works by targeting the receptors for two hormones: GIP and GLP-1, which are involved in appetite, blood sugar, and metabolism.

Maybe be referred to as a "dual agonist", "double G" weight-loss medicine, or GLP2.

TR is 30mg of active content per vial.

 it is given as a once-weekly injection under the skin (subcutaneous injection.

Storage:

• Store unopened vials at 2–8 °C. For extended preservation, maintain at ≤–20 °C.

• Keep the vial sealed until ready to use.

• Minimize exposure to moisture and direct light.

• Allow the vial to equilibrate before opening to avoid moisture condensation.

• After reconstitution, store at 2–8 °C following laboratory protocol.

• Avoid repeated freeze-thaw cycles to preserve peptide integrity.

Storage

• Store reconstituted product refrigerated at 2–8°C (36–46°F).

• Protect from light.

• Do not freeze reconstituted product.

• Avoid repeated temperature fluctuations.

• Keep the vial tightly closed and properly labeled.